Rodan + FieldsLash Boost aims to help condition and strengthenlashes.
As part of the agreement, Rodan + Fields has offered to pay $38 million.
They also don’t need to provide proof of purchase.
Allure/Courtesy of brand
The lash-growth treatment, Latisse, for example, contains a prostaglandin analog called bimatoprost.
The FDA has previously claimed lash growth products with isopropyl cloprostenate need to be classified as drugs and regulated.
In 2011, theFDA sent a warning letterto a company using the ingredient for lash and eyebrow products.
The letter noted that the products were essentially “unapproved new drugs.”
